AstraZeneca International - Glossary of medical and financial terms

S

Schizophrenia: A psychiatric condition in which the patient suffers impairment of their perception of reality.
SCLC: Small cell lung cancer.
Second-line therapy: Treatment administered after the failure of, or in addition to, first-line therapy.
Securities and Exchange Commission (SEC): US governmental agency that regulates the securities industry/stock market.
SEK, kronor, krona: References to Swedish currency.
Senior Executive Team (SET): a cross-functional, cross-territorial group, established and led by the Chief Executive Officer.
Sepsis: A life-threatening condition resulting from uncontrolled severe infections.
SG&A: costs Selling, general and administrative costs.
SHE: Safety, Health and the Environment.
Small molecule: A general term used to describe pharmaceutical R&D using chemistry and chemical methods and materials to discover and develop new medicines. Chemical molecules are small compared with biological molecules.
Specialist care: The medical care the patient receives after being referred by the primary care provider.
SR: Sustained-release.
SSE: Stockholm Stock Exchange.
Statin: A class of drugs that alter cholesterol levels in the blood.
Sterling, £, GBP, pence or p: References to UK currency.
Supplemental new drug application (sNDA): An application made to the US Food and Drug Administration to seek approval to market a marketed drug for another indication.
Systemic lupus erythematosus (SLE): A disease of the immune system (the system that prevents and fi ghts infection).